尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Rastetter William H, 董事. Insider active across 4 companies, notably Fate Therapeutics INC. In total, 13 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €1.9m. Activity tracked since 2 June 2021. The latest transaction was disclosed on 5 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
RASTETTER WILLIAM H is a Director at Neurocrine Biosciences INC, Regulus Therapeutics Inc., Fate Therapeutics INC and ILLUMINA INC. Across 13 filings in total, the 13 sampled filings cover the period from 2016-01-04 to 2025-11-06 and show EUR 0 of buys and EUR 1905025 of sells, with Levée d'options as the most frequent transaction nature.